Patients admitted in ICU after sucessfully resuscitated cardiac arrest and developping a refractory shock MedDRA version: 8.1 Level: LLT Classification code 10047146 Term: Vasopressin
Conditions
Interventions
Trade Name: PITRESSIN
Product Name: Arginine Vasopressine (Pitressin)
Pharmaceutical Form: Intravenous infusion
Other descriptive name: VASOPRESSIN
Concentration unit: IU international unit(s)
Concent
Sponsors
RER Saint Denis
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patient admitted after successfully resuscitated cardiac arrest requiring high level of vasopressor support Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Age <18 Cardiac index < 2.5 l/min/square meter or Svo2 < 70%
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: A decrease of the need of vasopressor support.;Secondary Objective: Evolution of venous oxygen saturation and organ dysfunction score (LOD, SOFA);Primary end point(s): Decrease in the need of vasopressor support | — |
Countries
France
Outcome results
None listed